Cargando…
Outcomes of dose-adjusted Berlin–Frankfurt–Münster-90 regimen without radiotherapy in adolescents and adults with T cell lymphoblastic lymphoma
The aim of this study was to evaluate the outcomes using the dose-adjusted Berlin–Frankfurt–Munster (BFM-90) regimen without radiotherapy in adolescents and adults with T cell lymphoblastic lymphoma (T-LBL) at Beijing Cancer Hospital. Between March 2004 and December 2013, 57 newly diagnosed T-LBL pa...
Autores principales: | Xie, Yan, Zhang, Yuntao, Zheng, Wen, Wang, Xiaopei, Lin, Ningjing, Tu, Meifeng, Ping, Lingyan, Ying, Zhitao, Zhang, Chen, Liu, Weiping, Deng, Lijuan, Song, Yuqin, Zhu, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4353872/ https://www.ncbi.nlm.nih.gov/pubmed/25752875 http://dx.doi.org/10.1007/s12032-015-0551-9 |
Ejemplares similares
-
Acute lymphoblastic leukemia: A single center experience with Berlin, Frankfurt, and Munster-95 protocol
por: Radhakrishnan, Venkatraman, et al.
Publicado: (2015) -
PEG-asparaginase in BFM-90 regimen improves outcomes in adults with newly diagnosed lymphoblastic lymphoma
por: Zheng, Wen, et al.
Publicado: (2017) -
Gemtuzumab ozogamicin in children with relapsed or refractory acute myeloid leukemia: a report by Berlin-Frankfurt-Münster study group
por: Niktoreh, Naghmeh, et al.
Publicado: (2019) -
Sinusoidal obstruction syndrome in a paediatric patient with acute lymphoblastic leukaemia after completion of reinduction therapy according to ALL Intercontinental Berlin-Frankfurt-Münster 2009
por: Pawlik-Gwozdecka, Dorota, et al.
Publicado: (2018) -
Safety and efficacy of bevacizumab combined with R-CHOP regimen in seven Chinese patients with untreated diffuse large B-cell lymphoma
por: Fu, Zhiying, et al.
Publicado: (2014)